Pura Vida Investments, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Pura Vida Investments, LLC disclosed 8 US equity positions worth $16.6m in its Q2 2025 13F filing. The largest position was BBNX at 37.6% of the reported book, followed by IMDX and CAI. Against the Q1 2025 filing, it opened 1 new position, added to 4 and reduced 2 among the top 8 holdings.
What did Pura Vida Investments, LLC own in Q2 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | BBNX BETA BIONICS INC | Healthcare | 37.6% | $6.2m | 2,500 | -99% | reduced |
| 2 | IMDX INSIGHT MOLECULAR DIA INC | 17.2% | $2.9m | 18,700 | -98% | reduced | |
| 3 | CAI CARIS LIFE SCIENCES INC | Healthcare | 14.5% | $2.4m | 45,000 | – | new |
| 4 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 11.6% | $1.9m | 89,940 | 100% | added |
| 5 | OM OUTSET MED INC | 8.2% | $1.4m | 429,120 | 8482% | added | |
| 6 | NSPR INSPIREMD INC | 6.1% | $1.0m | 450,517 | 0% | held | |
| 7 | NTRA NATERA INC | Healthcare | 2.5% | $422.4k | 245,691 | 9728% | added |
| 8 | MGX METAGENOMI INC | 2.4% | $391.3k | 952,134 | 260% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.